Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 181
Management of Diabetes in Patients with ESRD and CKD: Therapeutic Options and Considerations
Management of Diabetes in Patients with ESRD and CKD: Therapeutic Options and Considerations
David Baldwin, Jr., MD
Rush University, Chicago, IL
from Clinical Endocrinology Update 2017 on September 24, 2017 7:55 AM-8:25 AM
Debate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Debate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Willy M. Valencia, MD, MSc
Miami VA Medical Center, Miami, FL
from Clinical Endocrinology Update 2017 on September 24, 2017 10:55 AM-11:40 AM
Debate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Debate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Carol H. Wysham, MD
Rockwood Clinic, Spokane, WA
from Clinical Endocrinology Update 2017 on September 24, 2017 10:55 AM-11:40 AM
Debate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Rebuttal: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Willy M. Valencia, MD, MSc
Miami VA Medical Center, Miami, FL
from Clinical Endocrinology Update 2017 on September 24, 2017 10:55 AM-11:40 AM
Debate: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Rebuttal: What's Next After Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease?
Carol H. Wysham, MD
Rockwood Clinic, Spokane, WA
from Clinical Endocrinology Update 2017 on September 24, 2017 10:55 AM-11:40 AM
Q&A/Panel Discussion with Drs. Carlson, Wysham, and Valencia
Q&A/Panel Discussion with Drs. Carlson, Wysham, and Valencia
Anders L. Carlson, MD
International Diabetes Center, Saint Paul, MN
Carol H. Wysham, MD
Rockwood Clinic, Spokane, WA
Willy M. Valencia, MD, MSc
Miami VA Medical Center, Miami, FL
from Clinical Endocrinology Update 2017 on September 24, 2017 11:40 AM-11:55 AM
Challenging Cases from Surgeons and Endocrinologists
A Dilemma of Neuroendocrine Proportion
TK Pandian, MD
Mayo Clinic, Rochester, MN
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
Refractory Cushing's Disease
Andrew J Swearingen, MD
Cleveland Clinic, Cleveland, OH
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
Primary Hyperparathyroidism: A New Diagnostic Pitfall
Kristina Nicholson, MD
University of Pittsburgh, Pittsburgh, PA
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
A Case of Rapidly Progressive Thyroid Carcinoma with Rare and Unexpected Pathology
Hunter J Underwood, MD
NYU Langone Medical Center, New York, NY
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
A 74 Year-old Male with Endocrinological Eye Exam
Alexander L Shifrin, MD
Jersey Shore University Medical Center, Neptune, NJ
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
High Pressure Decision Points
Philip W Smith, MD
University of Virginia, Charlottesville, VA
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
Embryological Symmetry As the Basis for Finding Missing Parathyroid Adenomas
Anton F Engelsman
Royal North Shore Hospital, University of Sydney, Sydney, Australia
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
Curious Case of Two Glands and a Zebra
Kathleen C Gallagher
Vanderbilt University Schood of Medicine, Nashville, TN
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Linking Lipid Metabolism to Cardiometabolic Disease
Adipose Tissue Plasticity and Cardiometabolic Risk
Michael Dennis Jensen, MD
Mayo Clinic, Rochester, MN
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Linking Lipid Metabolism to Cardiometabolic Disease
Fat Catabolism in Cardiometabolic Disease: Friend or Foe?
Erin E Kershaw, MD
University of Pittsburgh, Pittsburgh, PA
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Linking Lipid Metabolism to Cardiometabolic Disease
Adipose Tissue Dynamics in Metabolism
Steven R Smith, MD
Florida Hospital, Orlando, FL
from ENDO 2017 on April 1, 2017 9:45 AM-11:15 AM
Co-Morbidities in Diabetes and Cardiovascular Disease
Co-Morbidities in Diabetes and Cardiovascular Disease
Janet B McGill, MD
Washington University School of Medicine, Saint Louis, MO
from ENDO 2017 on April 1, 2017 2:30 PM-3:15 PM
Corporate Liaison Board Forum: The Future of Clinical Trial Design
Chair
Ramon Espaillat, MD
AbbVie Inc., North Chicago, IL
from ENDO 2017 on April 2, 2017 4:45 PM-5:45 PM
Corporate Liaison Board Forum: The Future of Clinical Trial Design
Diversity of Engaging Patients in Clinical Trials and Incorporating the Patient Voice in Trial Design
Nicky Kelepouris, MD
Pfizer Innovative Health, Collegeville, PA
from ENDO 2017 on April 2, 2017 4:45 PM-5:45 PM
Corporate Liaison Board Forum: The Future of Clinical Trial Design
Panel Discussion: Building a Bridge Between Industry and Academia to Enroll Patients
Janet B McGill, MD
Washington University School of Medicine, Saint Louis, MO
from ENDO 2017 on April 2, 2017 4:45 PM-5:45 PM
Corporate Liaison Board Forum: The Future of Clinical Trial Design
Panel Discussion: Building a Bridge Between Industry and Academia to Enroll Patients
Ramon Espaillat, MD
AbbVie Inc., North Chicago, IL
from ENDO 2017 on April 2, 2017 4:45 PM-5:45 PM
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
Mechanisms of Enhanced Cardiovascular Disease with Type 2 Diabetes
Matthew Aaron Cavender, MD, MPH
University of North Carolina, Chapel Hill, NC
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
Cardiovascular Benefits and Consequences of Diabetes Medications
Jennifer Brigitte Green, MD
Duke Univ Med Ctr, Durham, NC
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Don't Stress Your Heart Out: Corticosteroids and Cardiovascular Function
Chair
Peter J Fuller, BMedSci MBBS PhD FRACP
MIMR-PHI Institute of Medical Research, Clayton VIC, Australia
from ENDO 2017 on April 3, 2017 4:30 PM-6:00 PM
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 181